Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells

被引:185
|
作者
Huang, Wen-Chin [1 ]
Li, Xiangyan [1 ]
Liu, Jian [2 ]
Lin, Jentai [3 ]
Chung, Leland W. K. [1 ]
机构
[1] Cedars Sinai Med Ctr, Urooncol Res Program, Dept Med, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[3] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan
关键词
ELEMENT-BINDING PROTEINS; FATTY-ACID SYNTHASE; FARNESYL DIPHOSPHATE SYNTHASE; BOUND TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; METABOLIC ONCOGENE; STEROL REGULATION; NUCLEAR-PROTEIN; KINASE-A; IN-VITRO;
D O I
10.1158/1541-7786.MCR-11-0206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously reported that sterol regulatory element-binding protein-1 (SREBP-1) is involved in the transcriptional regulation of androgen receptor (AR) and formation of fatty acid through altered expression of fatty acid synthase (FASN). In this article, we provide a new finding that SREBP-1 induced oxidative stress in prostate cancer cells through increased production of reactive oxygen species (ROS) and expression of NADPH oxidase 5 (Nox5). We have shown that (i) expression of SREBP-1 protein is positively associated with the clinical Gleason grades in human prostate cancer; (ii) genetic overexpression or knockdown of SREBP-1 in prostate cancer cells resulted in corresponding increased or decreased AR, FASN and Nox5 expression, fatty acid and lipid droplet accumulation, and ROS generation; and (iii) SREBP-1 induces and promotes the growth, migration, invasion, and castration-resistant progression of prostate cancer cells in vitro and in vivo. Our data show a novel molecular mechanism by which SREBP-1 promotes prostate cancer growth and progression through alterations in the concerted intracellular metabolic and signaling networks involving AR, lipogenesis, and ROS in prostate cancer cells. Mol Cancer Res; 10(1); 133-42. (C) 2011 AACR.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [31] Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation
    Xie, Hongjun
    Liu, Tianjie
    Chen, Jiaqi
    Yang, Zhao
    Xu, Shan
    Fan, Yizeng
    Zeng, Jin
    Chen, Yule
    Ma, Zhenkun
    Gao, Yang
    He, Dalin
    Li, Lei
    CANCER LETTERS, 2019, 453 : 193 - 205
  • [32] Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence
    Shah, RB
    Ghosh, D
    Pienta, K
    Elder, JT
    MODERN PATHOLOGY, 2005, 18 : 163A - 163A
  • [33] Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence
    Shah, RB
    Ghosh, D
    Pienta, K
    Elder, JT
    LABORATORY INVESTIGATION, 2005, 85 : 163A - 163A
  • [34] Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells
    Hsieh, Chen-Lin
    Cai, Changmeng
    Giwa, Ahmed
    Bivins, Aaronica
    Chen, Shao-Yong
    Sabry, Dina
    Govardhan, Kumara
    Shemshedini, Lirim
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2008, 41 (1-2) : 13 - 23
  • [35] Androgen dprivation trigers NFkB activation in prostate cancer cells: A critical step of androgen-independent progression
    Konaka, H
    Cinar, B
    Kubo, H
    Namiki, M
    Chung, LW
    Zhou, HYE
    JOURNAL OF UROLOGY, 2003, 169 (04): : 84 - 84
  • [36] Androgen Receptor Requires JunD as a Co-activator to Switch on an Oxidative Stress Generation Pathway in Prostate Cancer Cells
    Mehraein-Ghomi, Farideh
    Basu, Hirak S.
    Church, Dawn R.
    Wilding, George
    CANCER RESEARCH, 2010, 70
  • [37] GNL3 promotes prostate cancer growth by regulating androgen receptor protein stability
    Cheung, Edwin
    Zhang, Cuiting
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [38] Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G1 to S Phase
    Murthy, Shalini
    Wu, Min
    Bai, V. Uma
    Hou, Zizheng
    Menon, Mani
    Barrack, Evelyn R.
    Kim, Sahn-Ho
    Reddy, G. Prem-Veer
    PLOS ONE, 2013, 8 (02):
  • [39] Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist
    Chuu, Chih-pin
    Hiipakka, Richard A.
    Kokontis, John M.
    Fukuchi, Junichi
    Chen, Rou-Yu
    Liao, Shutsung
    CANCER RESEARCH, 2006, 66 (13) : 6482 - 6486
  • [40] A structural role of androgen receptor in progression of prostate cancer cells from G1 to S phase
    Murthy, Shalini
    Chinnakannu, Kannagi
    Wu, Min
    Kim, Sahn-Ho
    Barrack, Evelyn R.
    Reddy, Prem-Veer G.
    CANCER RESEARCH, 2012, 72